UPDATE: Retrophin (RTRX) Granted Orphan Drug Destination for PKAN Treatment
Tweet Send to a Friend
(Updated - May 5, 2015 5:32 PM EDT)
Retrophin (NASDAQ: RTRX) has been granted orphan drug designation for the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Retrophin (NASDAQ: RTRX) has been granted orphan drug designation for the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
